BGF

Activity from announced rounds

Activity in this selectionJun 30, 2026 · Jun 1, 2026
Rounds participated in
3
Confirmed lead rounds
1
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$102M
3 disclosed · full round size, not this investor’s share

By stage

Seed1
Series B1
Undisclosed1

By primary sector

Biotech1
Climate tech1
Healthtech1

By country

United Kingdom2
Ireland1

Rounds

3 in this selection
Gaussion

Gaussion develops magnetic-field control technology to improve lithium-ion battery performance.

$28MFunding round
Lead
CroíValve

Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease

$27MSeries B
Role not disclosed
TRIMTECH Therapeutics

Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases

$47MSeed+
Role not disclosed